US EditionJavelin Appoints Robin Robinson to Board of Directors
Summary by Citybiz
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Javelin Appoints Robin Robinson to Board of Directors
WOBURN, Mass.–(BUSINESS WIRE)–Javelin, a pioneer in human-centric preclinical drug discovery, today announced the appointment of Robin Robinson, PhD to its Board of Directors, effective February 2025. This strategic addition comes at a pivotal time, as the pharmaceutical industry accelerates its transition from traditional animal models to advanced human-based approaches in drug development. Embracing the Future: The FDA Modernization Act and H…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
